Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activity.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2004-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389557043487411PMID 14965286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor trafficking and the plasticity of excitatory synapses.

  2002cited by this paper
• 9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.

  2002cited by this paper
• Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.

  2001cited by this paper
• Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.

  2001cited by this paper
• Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.

  2001cited by this paper
• Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.

  2000cited by this paper
• 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists.

  2000cited by this paper
• 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.

  2000cited by this paper
• Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo.

  1999cited by this paper
• Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazephine AMPA antagonists.

  1999cited by this paper
• Glutamate in CNS disorders as a target for drug development: an update.

  1998cited by this paper
• Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion.

  1998cited by this paper
• ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

  1998cited by this paper
• 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor.

  1994cited by this paper
• (3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist.

  1993cited by this paper
• Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.

  1993cited by this paper
• Molecular diversity of glutamate receptors and implications for brain function.

  1992cited by this paper
• 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

  1990cited by this paper
• Chaotropic Ions Affect the Conformation of Quisqualate Receptors in Rat Cortical Membranes

  1988cited by this paper
• Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures.

  1984cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper

• Synthesis and biological evaluation of certain 3-substituted benzylideneamino-2-(4-nitrophenyl)quinazolin-4(3H)-one derivatives

  2015cites this paper
• Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.

  2015cites this paper
• Ion Channels – Ligand Gated

  2007cites this paper
• Synthesis and Structure—Activity Relationship of 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with in vivo Activity

  2004cites this paper